- Home
- ZUMZ vs NMRA Comparison
ZUMZ vs NMRA Comparison
Compare ZUMZ & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ZUMZ | NMRA |
|---|---|---|
| Founded | 1978 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 307.1M | 302.0M |
| IPO Year | 2005 | 2023 |
Fundamental Metrics
Financial Performance| Metric | ZUMZ | NMRA |
|---|---|---|
| Price | $18.85 | $1.70 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 8 |
| Target Price | ★ $18.00 | $7.50 |
| AVG Volume (30 Days) | 230.8K | ★ 634.9K |
| Earning Date | 06-04-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 966.67 | 5.23 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $929,057,000.00 | N/A |
| Revenue This Year | $4.30 | N/A |
| Revenue Next Year | $3.30 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 4.48 | N/A |
| 52 Week Low | $15.00 | $0.83 |
| 52 Week High | $31.70 | $3.65 |
Technical Indicators
Market Signals| Indicator | ZUMZ | NMRA |
|---|---|---|
| Relative Strength Index (RSI) | 46.10 | 56.46 |
| Support Level | $18.37 | $1.67 |
| Resistance Level | $19.16 | $1.85 |
| Average True Range (ATR) | 0.73 | 0.09 |
| MACD | -0.04 | 0.01 |
| Stochastic Oscillator | 14.39 | 85.00 |
Price Performance
Historical ComparisonAbout ZUMZ Zumiez Inc.
Zumiez Inc is a United States-based specialty retailer engaged in the sale of apparel, footwear, accessories, and hard goods. The company provides merchandise with cultural elements coming from fashion, music, art, action sports, streetwear, and other lifestyles. The company operates under the brands Zumiez, Fast Times, and Blue Tomato, and through both physical stores and websites. The majority of the company's stores are located in the U.S., with the rest in Canada, Australia, and Europe. The U.S. market contributes to the majority of the company's revenue.
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.